The abundance of information available online about cancer can be overwhelming for patients seeking quick, accurate, and reliable news and updates. An “infodemic” was declared by the World Health Organization and United Nations due to the proliferation of...
A few months ago, two sisters published an essay in The New York Times about their genetic testing journey, which started because their mother was found to have a mutation in one of the BRCA genes. People who have a mutation in one of the BRCA genes are at increased...
Dr. William G. Kaelin, Jr., Sir Peter J. Ratcliffe, and Dr. Gregg L. Semenza won the 2019 Nobel Prize in Physiology or Medicine for their work related to a genetic condition called von Hippel-Lindau syndrome (VHL). VHL is a hereditary cancer syndrome that is...
Paired tumor/germline testing is far from standard practice in cancer care, but some experts in the field are advocating that when patients have their tumors genomically profiled to determine precision medicine options, that is an opportunity to also evaluate them for...
In 2019, the field of personalized medicine continued to grow with the market launch of more than two dozen drugs targeting novel genomic alterations and numerous genetic tests to determine whether patients are at risk for serious diseases like cancer, and whether...